Drobuline hydrochloride

CAS No. 68162-52-7

Drobuline hydrochloride( —— )

Catalog No. M26177 CAS No. 68162-52-7

Drobuline hydrochloride has the action of cardiac inhibitor, often used for anti-arrhythmia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 307 In Stock
5MG 283 In Stock
10MG 413 In Stock
25MG 644 In Stock
50MG 848 In Stock
100MG 1097 In Stock
200MG Get Quote In Stock
500MG 2213 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Drobuline hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Drobuline hydrochloride has the action of cardiac inhibitor, often used for anti-arrhythmia.
  • Description
    Drobuline hydrochloride has the action of cardiac inhibitor, often used for anti-arrhythmia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    MKLP-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    68162-52-7
  • Formula Weight
    319.87
  • Molecular Formula
    C19H26ClNO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.CC(C)NCC(O)CC(c1ccccc1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Labrière C, et al. Further investigation of Paprotrain:Towards the conception of selective and multi-targeted CNS kinase inhibitors. Eur J Med Chem. 2016 Nov 29;124:920-934.
molnova catalog
related products
  • 5-O-Methylhierochin ...

    5-O-Methylhierochin D is a natural product for research related to life sciences.

  • PAR-3 (1-6) amide (m...

    SFNGGP-NH2 is a biological active peptide. (PAR-3 is a high-affinity thrombin receptor. PAR-3 mRNA is expressed in the cutaneous mast cells of humans. Protease-Activated Receptors (PARs) have been studied for their roles in itch and their itch-associated response through histamine-dependent/independent pathways have been reported. PAR-3 has been shown not to induce itching alone but possibly in conjunction with PAR-4. Co-expression of PAR-3 and PAR-4 enhances thrombin action suggesting that PAR-3 alone does not mediate transmembrane signaling but instead functions as a cofactor to activate PAR-4.)

  • Picrasidine I

    Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.